Biotechnology
Healthcare
Investing News
Life Style
Market News
Medical Use
Pharmaceutical
Products
The Market Buzz
Your Environment
Regeneron CEO Says its Covid Antibody Treatment Protects for up to 8 Months
Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) says that within its late-stage trial, a single dose of its antibody cocktail decreased the risk of contracting Covid-19 by 81.6%. The company’s shares...
